UK markets closed

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
65.00-1.53 (-2.30%)
At close: 04:00PM EDT
65.00 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts13131414
Avg. Estimate-0.18-0.13-0.531.16
Low estimate-0.25-0.26-0.89-0.33
High estimate-0.08-0.03-0.283.05
Year ago EPS-0.45-0.25-1.46-0.53
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts12121414
Avg. Estimate158.89M171.86M663.49M931.92M
Low estimate155.01M164.74M653M846.99M
High estimate162.16M175.6M675.7M1.03B
Year ago sales110.79MN/A464.37M663.49M
Sales growth (year/est)43.40%N/A42.90%40.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.59-0.57-0.44-0.32
Actual EPS-0.45-0.25-0.3-0.16
Difference0.140.320.140.16
Surprise %23.70%56.10%31.80%50.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.18-0.13-0.531.16
7 days ago-0.18-0.13-0.551.06
30 days ago-0.22-0.12-0.711.14
60 days ago-0.21-0.12-0.671.28
90 days ago-0.23-0.15-0.551.42
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days111N/A
Up last 30 days9487
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesITCIIndustrySector(s)S&P 500
Current qtr.60.00%N/AN/AN/A
Next qtr.48.00%N/AN/AN/A
Current year63.70%N/AN/AN/A
Next year318.90%N/AN/AN/A
Next 5 years (per annum)291.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A